Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus

Author： Billich A.   Aschauer H.   Aszodi A.   Stuetz A.  

Publisher： Elsevier

ISSN： 0378-5173

Source： International Journal of Pharmaceutics, Vol.269, Iss.1, 2004-01, pp. : 29-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema

By Prucha Hanna   Schnopp Christina   Akdis Cezmi   Lauener Roger   Wollenberg Andreas   Ring Johannes   Traidl-Hoffmann Claudia  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1507-1516

Informa Healthcare

Access to resources Recommend Favorite

Atopic dermatitis: can tacrolimus or pimecrolimus scratch the itch?

By  

Inpharma, Vol. 1, Iss. 1477, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

In vitro percutaneous absorption of genistein from topical gels through human skin

By Chadha Gurkishan   Sathigari Sateeshkumar   Parsons Daniel L.   Jayachandra Babu R.  

Drug Development and Industrial Pharmacy, Vol. 37, Iss. 5, 2011-05 ,pp. : 498-505

Informa Healthcare

Access to resources Recommend Favorite

Boxed warning recommended for tacrolimus/pimecrolimus

By  

Reactions Weekly, Vol. 1, Iss. 1040, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Topical Calcineurin Inhibitors, Pimecrolimus and Tacrolimus

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 3, 2007-01 ,pp. : 237-243

Bentham Science Publishers

Access to resources Recommend Favorite